The adverse prognostic value of high Shannon index prior to neoadjuvant chemotherapy is in line with our previous study14 which showed the prognostic value of high Shannon indices for gene CNV using c-MYC and FGFR1 in treatment-naïve breast cancer patients. This evidence concerns the gene MYC and breast carcinoma.